These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 29867139)

  • 21. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
    Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
    Elife; 2022 Sep; 11():. PubMed ID: 36069759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
    Maguire JA; Cardenas-Diaz FL; Gadue P; French DL
    Curr Protoc Stem Cell Biol; 2019 Feb; 48(1):e64. PubMed ID: 30358158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
    Chadwick AC; Wang X; Musunuru K
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells.
    Li G; Zhang X; Zhong C; Mo J; Quan R; Yang J; Liu D; Li Z; Yang H; Wu Z
    Sci Rep; 2017 Aug; 7(1):8943. PubMed ID: 28827551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving Precise CRISPR Genome Editing by Small Molecules: Is there a Magic Potion?
    Bischoff N; Wimberger S; Maresca M; Brakebusch C
    Cells; 2020 May; 9(5):. PubMed ID: 32466303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Transcriptomic Analysis to Assess Double-Strand Break Repair Activity: Towards Precise in vivo Genome Editing.
    Pasquini G; Cora V; Swiersy A; Achberger K; Antkowiak L; Müller B; Wimmer T; Fraschka SA; Casadei N; Ueffing M; Liebau S; Stieger K; Busskamp V
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
    Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
    Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rates of homology directed repair of CRISPR-Cas9 induced double strand breaks are lower in naïve compared to primed human pluripotent stem cells.
    Dodsworth BT; Hatje K; Meyer CA; Flynn R; Cowley SA
    Stem Cell Res; 2020 Jul; 46():101852. PubMed ID: 32521498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases.
    Renaud JB; Boix C; Charpentier M; De Cian A; Cochennec J; Duvernois-Berthet E; Perrouault L; Tesson L; Edouard J; Thinard R; Cherifi Y; Menoret S; Fontanière S; de Crozé N; Fraichard A; Sohm F; Anegon I; Concordet JP; Giovannangeli C
    Cell Rep; 2016 Mar; 14(9):2263-2272. PubMed ID: 26923600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
    Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
    Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.
    Maruyama T; Dougan SK; Truttmann MC; Bilate AM; Ingram JR; Ploegh HL
    Nat Biotechnol; 2015 May; 33(5):538-42. PubMed ID: 25798939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage.
    Zhang JP; Li XL; Li GH; Chen W; Arakaki C; Botimer GD; Baylink D; Zhang L; Wen W; Fu YW; Xu J; Chun N; Yuan W; Cheng T; Zhang XB
    Genome Biol; 2017 Feb; 18(1):35. PubMed ID: 28219395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis-dependent repair of Cpf1-induced double strand DNA breaks enables targeted gene replacement in rice.
    Li S; Li J; Zhang J; Du W; Fu J; Sutar S; Zhao Y; Xia L
    J Exp Bot; 2018 Sep; 69(20):4715-4721. PubMed ID: 29955893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection.
    Mitzelfelt KA; McDermott-Roe C; Grzybowski MN; Marquez M; Kuo CT; Riedel M; Lai S; Choi MJ; Kolander KD; Helbling D; Dimmock DP; Battle MA; Jou CJ; Tristani-Firouzi M; Verbsky JW; Benjamin IJ; Geurts AM
    Stem Cell Reports; 2017 Mar; 8(3):491-499. PubMed ID: 28238794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases.
    Yang D; Scavuzzo MA; Chmielowiec J; Sharp R; Bajic A; Borowiak M
    Sci Rep; 2016 Feb; 6():21264. PubMed ID: 26887909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization.
    Roberts B; Haupt A; Tucker A; Grancharova T; Arakaki J; Fuqua MA; Nelson A; Hookway C; Ludmann SA; Mueller IA; Yang R; Horwitz R; Rafelski SM; Gunawardane RN
    Mol Biol Cell; 2017 Oct; 28(21):2854-2874. PubMed ID: 28814507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Level Precise Knockin of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells.
    Wen W; Cheng X; Fu Y; Meng F; Zhang JP; Zhang L; Li XL; Yang Z; Xu J; Zhang F; Botimer GD; Yuan W; Sun C; Cheng T; Zhang XB
    Stem Cell Reports; 2018 Jun; 10(6):1821-1834. PubMed ID: 29754960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
    Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
    J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.